Reacta Healthcare, founded in 2013 and headquartered in the United Kingdom, is at the forefront of marrying medicine with food science, underscored by their slogan: Integrating Medicine with Food Science. Specializing in the development and manufacturing of challenge meals, they are crucial for conducting food allergy clinical trials.
The company stands at the intersection of the Manufacturing and Pharmaceutical industries, offering cutting-edge solutions within the food allergy sector. By capitalizing on their foundational expertise, Reacta Healthcare positions itself as an innovative player in advancing therapeutic and diagnostic approaches for food allergies.
The company's last investment was a spinout investment on the 1st of January 2015, backed by University Ventures. For investors, Reacta Healthcare represents a unique opportunity to invest in a niche market with promising growth prospects, leveraging their expertise in both medicine and food science within a growing healthcare niche.